930303-26-7 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Methylpyridine-2-boronic acid is used as a reagent for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to participate in a wide range of organic reactions, facilitating the creation of new and innovative drug molecules.
Used in Agrochemical Development:
In the agrochemical industry, 3-Methylpyridine-2-boronic acid is utilized as a reagent for the synthesis of various agrochemicals. Its ability to engage in diverse chemical reactions contributes to the development of new and effective compounds for agricultural applications.
Used in Fine Chemicals Production:
3-Methylpyridine-2-boronic acid is employed as a reagent in the production of fine chemicals. Its versatility in organic synthesis enables the creation of high-quality specialty chemicals for various applications.
Used in Material Science:
In the field of material science, 3-Methylpyridine-2-boronic acid is used in the development of new materials. Its unique properties and reactivity contribute to the advancement of material technologies and the discovery of novel materials with specific properties.
Used in Chemical Research:
3-Methylpyridine-2-boronic acid is utilized in the study of various chemical reactions. Its involvement in a broad spectrum of reactions provides valuable insights into reaction mechanisms and helps in understanding the fundamental principles of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 930303-26-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,3,0 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 930303-26:
(8*9)+(7*3)+(6*0)+(5*3)+(4*0)+(3*3)+(2*2)+(1*6)=127
127 % 10 = 7
So 930303-26-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H8BNO2/c1-5-3-2-4-8-6(5)7(9)10/h2-4,9-10H,1H3
930303-26-7Relevant academic research and scientific papers
TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
-
Paragraph 0600, (2015/06/03)
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula (I): wherein W, X, Y, Z, R1, R2, R5, and R8 are as described herein.
BI-ARYL AMINOTETRALINES
-
Page/Page column 17, (2010/03/04)
The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein R1-R5, A, B, Q, W, and X are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.
